U.S. Makes Initial Offers in Medicare Drug Price Negotiations

Why It Matters: The price offers kick off negotiations. The medicines selected for negotiations are taken by millions of Americans to treat conditions like diabetes, cancer and heart disease. The administration identified them in August, beginning a lengthy process intended to result in an agreed-upon price that would take effect in 2026, assuming the negotiation…

Read More